Ascendum Capital

EndoWays is a robotics company based in Tel Aviv, Israel, established in 2017. It specializes in the development of self-propelling micro-catheters designed to navigate complex and tortuous blood vessels. The company's innovative software platform enhances the capabilities of interventional radiologists and cardiologists, allowing them to perform intricate procedures in neurovascular, peripheral, and cardiac contexts. By utilizing a fully disposable robotic system, EndoWays aims to improve procedural efficiency, reduce operation time, and minimize radiation exposure for both patients and medical staff.

Broncus Medical develops innovative diagnostic and therapeutic navigation technologies aimed at treating lung diseases. The company offers a range of products, including the Archimedes System, which features bronchoscopic trans-parenchymal needle access for virtual bronchoscopic planning and navigation, and the Lungpoint Virtual Bronchoscopic Navigation system that enables real-time navigation within the lungs for biopsy procedures. Additionally, Broncus is advancing its Exhale product line, which includes the Airway Bypass procedure, a minimally-invasive treatment for homogeneous emphysema, a prevalent form of the disease. The company is currently conducting the pivotal EASE Trial to evaluate this treatment. Founded in 1997 and originally named Broncus Technologies, the company is headquartered in San Jose, California, with additional operations in Shanghai, China, and Mountain View, California. Broncus Medical focuses on addressing the unmet medical needs in interventional pulmonology, improving the diagnosis and treatment of lung cancer and chronic obstructive pulmonary disease (COPD).